IVF Spain is offering Early Embryo Viability Assessment (Eeva™) test. Eeva Designed to Improve IVF Outcomes.

LONDON, UK, 1st November 2013 – With an increasing number of UK couples travelling abroad for fertility treatment and Spain being amongst the most popular of the preferred destinations, IVF Spain is proud to be the first infertility clinic in Valencia Community  to make a ground-breaking new approach to IVF commercially available in Spain.

The 'Early Embryo Viability Assessment' (Eeva™) test, uses software to measure key scientifically and clinically validated cell-division parameters from video images. It is the first and only non-invasive IVF test clinically proven to improve the accuracy of selecting embryos that will likely grow to the blastocyst stage, a critical milestone in embryo development.

As women get older, their eggs are fewer and less likely to be fertilised and implanted in the womb. As stated by the HFEA[1], donated eggs can be their only chance, but there has been a shortage as demand has increased with waiting lists of around a year at some clinics, which has resulted in many women and couples seeking treatment abroad[2].

Infertility patients who would like to know more about travelling to Spain for IVF treatments should contact IVF Spain – Inge Kormelink on T: +34 965 267 890 / @ : i.kormelink@ivf-spain.com.

To find out more about the Eeva test you can visit www.eevaivf.com.

Or view a short video here explaining the Eeva test

--------

NOTES :

About Infertility and IVF

Infertility affects one of seven couples, or 3.5 million people, in the UK — many of whom try to conceive through IVF. The demand for assisted reproduction tools and procedures is growing by 5.9 percent per year in the UK, due to higher infertility rates caused by an increasing maternal age as more women are starting families later in life. The demand is growing despite the significant cost per cycle — £4000 to £8000 in the UK  — and the fact that only approximately one-third of cycles result in a live birth. This can lead to multiple cycles, leading to greater physical, emotional, practical and financial costs, before determining if pregnancy can be achieved. 

About IVF Spain

Our aim, at IVF Spain, is to make our patients feel comfortable and self-confident. Quality is something we work for each day improving constantly to be at the vanguard of new technologies in reproductive medicine. However, we do not only provide quality with our results, but also with our “know-how” for treating patients and the atmosphere in which we receive them.

Individuality and personalization are part of our main principles. Once the treatment has been decided and started, each of our patients will have their own personal assistant with whom they can communicate in their own language and who will be at their disposal at all times. In any case, patients may communicate directly with the doctors if the situation is required. Couples’ satisfaction is our priority.

IVF Spain will be at the London Fertility Show on 2 and 3 November - booth D84 and Dr. Natalia Szlarb will talk about ‘Going Abroad for Eggdonation’ on Sunday at 11.45am.

About the Early Embryo Viability Assessment (Eeva) Test

The Eeva test provides IVF clinicians with predictive information about the embryo’s development potential to help improve embryo selection. Eeva’s proprietary software automatically analyzes embryo development against scientifically and clinically validated cell-division parameters identified by researchers at Stanford University in the US. With results from the Eeva test, IVF teams now have predictive and objective information to combine morphological assessment to help improve the embryo selection decision. The Eeva Test was validated in a prospective, multi-centre, 54-patient clinical trial with 758 embryos. Embryologists using Eeva were significantly able to improve their ability to identify non-viable embryos relative to traditional methods alone. Additionally, Eeva was able to increase the consistency of embryo assessment across embryologists. Results of this study were presented in July 2012 at the European Society of Human Reproduction and Embryology (ESHRE) Annual Meeting and published by Conaghan et al in Fertility and Sterility, May 2013.

Eeva is currently CE Marked and available for use in the EU only. For a full list of clinics offering the Eeva test please visit www.eevaivf.com or follow us on Twitter @EevaIVF.

View videos of the technology on YouTube.

Eeva will be at the London Fertility Show on 2 and 3 November - booth 45

Media contacts: 


UK & International media – Sylvie Berrebi at sylvie@sciad.com +44-(0)-7795-197271 or Richard Anderson at richard@sciad.com ++44-(0)-7973-950376